Ovarian status influences the skeletal effects of tamoxifen in adult rats

Breast Cancer Research and Treatment

Volumn 41, Issue 1, 1996, Pages 71-79

  Sibonga, Jean D ^a   Evans, Glenda L ^a   Hauck, Eric R ^a   Bell, Norman H ^c   Turner, Russell T ^a,b  

^a MAYO CLINIC   (United States)

^b MAYO GRADUATE SCHOOL   (United States)

^c RALPH H JOHNSON VA MEDICAL CENTER   (United States)

Author keywords

Antiestrogen; Bone structure; Histomorphometry; Ovary intact rat; Tamoxifen

Indexed keywords

ESTROGEN; TAMOXIFEN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE ATROPHY; BREAST CANCER; CANCELLOUS BONE; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFECT; FEMALE; HUMAN; MORPHOMETRICS; NONHUMAN; OSSIFICATION; OSTEOLYSIS; OSTEOPOROSIS; OVARIECTOMY; OVARY FUNCTION; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TIBIA; TRABECULAR BONE;

NON-PROGRAMMATIC;

ANALYSIS OF VARIANCE; ANIMALS; ANTINEOPLASTIC AGENTS, HORMONAL; BONE AND BONES; BONE REMODELING; ESTROGEN ANTAGONISTS; ESTROGENS; FEMALE; OVARIECTOMY; RATS; TAMOXIFEN; TIBIA;

EID: 0029823585     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01807038     Document Type: Article

References (37)

1. Jordan VC: Long-term adjuvant Tamoxifen therapy for breast cancer. Breast Cancer Res Treat 15: 125-136, 1990
2. Cuzick J, Wang DY, Bulbrook RD: The prevention of breast cancer. Lancet 1: 83-86, 1986
3. Chlebowski RT, Butler J, Nelson A, Lillington L: Breast cancer chemoprevention. Cancer 72(3): 1032-1037, 1993
4. Ettinger B, Genant HK, Cann CE: Long-term estrogen replacement therapy prevents bone loss and fractures. Ann Intern Med 102: 319-324, 1985
5. Genant HK, Baylink DJ, Gallagher JC: Estrogens in the prevention of osteoporosis in postmenopausal women. Am J Obstet Gynecol 161: 1842-1846, 1989
6. Grady D, Rubin SM, Petitti DB, Fox CS, Black D, Ettinger B, Ernster VL, Cummings SR: Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med 117: 1016-1037, 1992
7. Turner RT, Wakley GK, Hannon KS, Bell NH: Tamoxifen prevents the skeletal effects of ovarian hormone deficiency in rats. J Bone Miner Res 2(5): 449-456, 1987
8. Turner RT, Vandersteenhoven JJ, Bell NH: The effect of OVX and 17β-estradiol on cortical bone histomorphometry in growing rats. J Bone Miner Res 2: 115-122, 1987
9. Turner RT, Wakley GK, Hannon KS, Bell NH: Tamoxifen inhibits osteoclast-mediated resorption of trabecular bone in ovarian hormone-deficient rats. Endocrinology 122(3): 1146-1150, 1988
10. Love RR, Mazess RB, Tormey DC, Barden HS, Newcomb PA, Jordan VC: Bone mineral density in women with breast cancer treated with adjuvant Tamoxifen for at least two years. Breast Cancer Res Treat 12: 297-301, 1988
11. Turken S, Siris E, Seidin D, Flaster E, Hyman G, Lindsay R: Effects of Tamoxifen on spinal bone density in women with breast cancer. J Natl Cancer Inst 81(4): 1086-1088, 1989
12. Fornander T, Rutqvist LR, Sjoberg HD, Blomqvist L, Mattsson A, Glas U: Long-term adjuvant Tamoxifen in early breast cancer: effect on bone mineral density in postmenopausal women. J Clin Oncology 8(6): 1019-1024, 1990
13. Jordan VC, Phelps E, Lindgren JU: Effects of antiestrogens on bone in castrated and intact female rats. Breast Cancer Res Treat 10: 31-35, 1987
14. Moon LY, Wakley GK, Turner RT: Dose-dependent effects of Tamoxifen on long bones in growing rats: influence of ovarian status. Endocrinology 129(3): 1568-1574, 1991
15. Kalu DN, Salerno E, Liu CC, Echon R, Ray M, Garza-Zapata M, Hollis BW: A comparative study of the actions of Tamoxifen, estrogen and progesterone in the ovariectomized rat. Bone Miner 15: 109-124, 1991
16. Feldmann S, Minne HW, Parvisi S, Pfeifer M, Lempert UG, Bauss R, Ziegler R: Antiestrogen and antiandrogen administration reduce bone mass in the rat. Bone Miner 7: 245-254, 1989
17. Baginsky ES, Marie SS, Zak B: Direct microdetermination of calcium. Clin Chim Acta 46: 49-54, 1973
18. Fiske CH, Subbarow Y: The colorimetric determination of phosphorus. J Biol Chem 66: 375-400, 1925
19. Jordan VC, Lababidi MK, Langan-Fahey S: Suppression of mouse mammary tumorigenesis by long-term Tamoxifen therapy. J Natl Cancer Inst 83: 492-496, 1991
20. The Breast Cancer Trials Committee: Adjuvant Tamoxifen in the management of operable breast cancer. Lancet 2: 171-175, 1987
21. Delozier T, Julien J, Juret P: Adjuvant Tamoxifen in postmenopausal breast cancer: Preliminary results of a randomized trial. Breast Cancer Res Treat 7: 105-110, 1986
22. Nolvadex Adjuvant Trial Organization: Controlled trial of Tamoxifen as single adjuvant agent in the management of early breast cancer. Lancet 1: 836-840, 1985
23. Evans G, Bryant HU, Magee D, Sato M, Turner RT: The effects of raloxifene on tibia histomorphometry in ovariectomized rats. Endocrinology 134(5): 2283-2288, 1994
24. Wronski TJ, Lowry PL, Walsh CC, Ignaszewski LA: Skeletal alterations in ovariectomized rats. Calcif Tissue Int 37: 324-328, 1985
25. Wronski TJ, Walsh CC, Ignaszewski LA: Histologic evidence for osteopenia and increased bone turnover in ovariectomized rats. Bone 7: 119-123, 1986
26. Belchetz PE: Hormonal treatment of postmenopausal women. N Engl J Med 300: 1062-1071, 1994
27. Gold E, Stapley S, Goulding A: Tamoxifen and norethisterone: effects of plasma cholesterol and total body calcium content in the estrogen-deficient rat. Horm Metab Res 26: 100-103, 1994
28. Turner RT, Evans GL, Wakley GK: Mechanism of action of estrogen on cancellous bone balance in tibiae of ovariectomized growing rats: inhibition of indices of formation and resorption. J Bone Miner Res 8(3): 359-366, 1993
29. Turner RT, Riggs BL, Spelsberg TC: Skeletal effects of estrogen. Endoc Rev 15(3): 275-300, 1994
30. Turner RT, Hannon KS, Demers L, Buchanan J, Bell NH: The differential effects of gonadal insufficiency on bone histomorphometry in male and female rats. J Bone Miner Res 4: 557-563, 1989
31. Oursler M, Osdoby P, Pyfferoen J, Riggs BL, Spelsberg TC: Avian osteoclasts as estrogen target cells. Proc Natl Acad Sci USA 88: 6613-6617, 1991
32. Komm BS, Terpening CM, Benz DJ, Graeme KA, Gallegos A, Kore M, Greene GL, O'Malley BW, Haussler MR: Estrogen binding, receptor mRNA, and biological response on osteoblast-like osteosarcoma cells. Science 241: 81-84, 1988
33. Eriksen ER, Colvard DS, Berg NJ, Graham ML, Mann KG, Spelsberg TC, Riggs BL: Evidence of estrogen receptors in normal human osteoblast-like cells. Science 241: 84-86, 1988
34. Fisher B, and other NSABP investigators: Prolonging Tamoxifen for primary breast cancer: findings from the National Surgical Adjuvant Breast & Bowel Project Clinical Trial. Ann Int Med 106: 649-654, 1987
35. Nayfield SG, Karp JE, Ford LG, Dorr FD, Kramer BS: Potential role of Tamoxifen in the prevention of breast cancer. J Natl Cancer Inst 83: 1450-1459, 1991
36. Ke HZ, Simmons HA, Pirie CM, Crawford DT, Thompson DD: Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats. Endocrinology 136 (6): 2435-2441, 1995
37. Powles TJ, Hickish TF, Kanis JA, Ashley S: Tamoxifen preserves bone mineral density in postmenopausal women but causes loss of bone density in premenopausal women. Proc Annu Meet Am Soc Clin Oncol 14: A344, 1995